Company Filing History:
Years Active: 2007
Title: Martin Nilsson: Innovator in Biotechnological Advancements
Introduction
Martin Nilsson is a prominent inventor based in Uppsala, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for medical diagnostics and therapeutics. His work focuses on the interaction between fibrinogen and specific proteins, which has implications for understanding and treating infections caused by staphylococcus epidermidis.
Latest Patents
Martin Nilsson holds a patent for "Antibodies to a fibrinogen binding protein of staphylococcus epidermidis." This invention involves a new fibrinogen binding protein or polypeptide derived from coagulase-negative staphylococci. The patent details biotechnological methods for producing the protein or polypeptide that exhibits fibrinogen binding activity. It also includes a recombinant DNA molecule coding for the protein, as well as micro-organisms containing this recombinant DNA. The invention further encompasses therapeutic and diagnostic applications, such as a diagnostic kit for identifying the presence and type of coagulase-negative staphylococci, along with a vaccine composition that includes the protein or DNA.
Career Highlights
Martin Nilsson is associated with Biostapro AB, where he continues to advance his research and development efforts. His work has been instrumental in bridging the gap between basic research and practical applications in the medical field. With a focus on innovative solutions, he has contributed to the understanding of bacterial infections and their treatment.
Collaborations
Martin has collaborated with notable colleagues, including Bengt Guss and Lars Frykberg. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to impactful innovations in biotechnology.
Conclusion
Martin Nilsson's contributions to biotechnology, particularly through his patent on fibrinogen binding proteins, highlight his role as an innovator in the field. His work not only advances scientific understanding but also paves the way for new diagnostic and therapeutic options.